Keppra (generic name levetiracetam) is an anti epileptic drug used to treat seizures in adults and children. There is growing evidence that switching from the brand-name Keppra to the generic form of Keppra (levetiracetam) can cause an increased rate of seizure. Many individuals report going seizure-free for years and then having a seizure shortly after switching to the generic drug. For anticonvulsant drugs, small variations in concentrations between the brand-name formulation and the generic formulation can cause toxic effects and seizures when taken by patents with epilepsy. A single breakthrough seizure due to a change in the amount of medication that is delivered can have devastating consequences, including loss of driver’s license, injury, and even death. We are currently investigating cases where individuals have suffered breakthrough seizures, injury or death after switching from the brand-name Keppra to the generic (levetiracetam) form of Keppra.
Lawyer: Roger Smith
Primary Contact: Linda Reynolds
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.